US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Video Games & Esports ETF

25.18

+0.18050.72%

Post-market: 25.190.0084+0.03%16:15 EDT

Volume:8.58K

Turnover:216.67K

Market Cap:78.82M

PE:-0.04

High:25.46

Open:25.13

Low:25.08

Close:25.00

52wk High:34.68

52wk Low:22.80

Shares:3.13M

Float Shares:3.13M

Volume Ratio:0.36

T/O Rate:0.27%

Dividend:0.48

Dividend Rate:1.92%

EPS(TTM):-662.1600

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Aardvark Therapeutics down 54% to $5.70 after pausing Phase 3 HERO trial

Aardvark Therapeutics voluntarily pauses Phase 3 HERO trial

Press Release: SurgePays Revenue for the Third Quarter 2025 Increases 292% Year-Over-Year and 62% Sequentially

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HERO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HERO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","market":"US","secType":"STK","nameCN":"Global X Video Games & Esports ETF","latestPrice":25.1816,"timestamp":1774641600000,"preClose":25.0011,"halted":0,"volume":8581,"hourTrading":{"tag":"盘后","latestPrice":25.19,"preClose":25.1816,"latestTime":"16:15 EDT","volume":14,"amount":352.5264,"timestamp":1774642503641,"change":0.0084,"changeRate":0.000334,"amplitude":0},"delay":0,"changeRate":0.007219682333977247,"floatShares":3130000,"shares":3130000,"eps":-662.16,"marketStatus":"Market Closed","change":0.1805,"latestTime":"03-27 16:00:00 EDT","open":25.13,"high":25.46,"low":25.08,"amount":216671.4711,"amplitude":0.015199,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-662.16,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1572494400000,"exchange":"NASDAQ","adjPreClose":25.0011,"sharesOutstanding":3230000,"nav":25.53,"aum":79914549.07,"dividendRate":0.019161,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.02,"preClose":25.0011,"latestTime":"09:05 EDT","volume":9,"amount":229.800015,"timestamp":1774616740457,"change":0.0189,"changeRate":0.000756,"amplitude":0.030799},"postHourTrading":{"tag":"盘后","latestPrice":25.19,"preClose":25.1816,"latestTime":"16:15 EDT","volume":14,"amount":352.5264,"timestamp":1774642503641,"change":0.0084,"changeRate":0.000334,"amplitude":0},"volumeRatio":0.36059773290377334,"impliedVol":0.0765,"impliedVolPercentile":0.4343},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","floatShares":3130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.36059773290377334,"shares":3130000,"dividePrice":0.4825,"high":25.46,"amplitude":0.015199,"preClose":25.0011,"low":25.08,"week52Low":22.8,"pbRate":"--","week52High":34.68,"institutionHeld":0.5073,"latestPrice":25.1816,"eps":-662.16,"divideRate":0.019161,"volume":8581,"delay":0,"ttmEps":-662.16,"open":25.13,"prevYearClose":29.7565,"prevWeekClose":25.355,"prevMonthClose":27.46,"prevQuarterClose":29.7565,"fiveDayClose":25.355,"twentyDayClose":27.46,"sixtyDayClose":29.8719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HERO\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HERO","amount":0.332932,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"HERO","amount":0.14964,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"HERO","amount":0.20754,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"HERO","amount":0.04107,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"},{"date":"2023-12-28","symbol":"HERO","amount":0.120779,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Global X Video Games & Esports ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HERO\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-08","value":0.027784,"currency":"USD"},{"executeDate":"2020-06-29","recordDate":"2020-06-30","paymentDate":"2020-07-08","value":0.012223,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.003605,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.025409,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.06645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HERO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HERO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621084925","title":"Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084925","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084925?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:05","pubTimestamp":1774296300,"startTime":"0","endTime":"0","summary":"Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 AR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260833/0/en/Aardvark-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0128526141.USD","LU1803068623.USD","AARD","LU0029864427.USD","HERO","LU0029874061.USD","LU0211327993.USD","LU1267930573.SGD","LU0054578231.USD","LU0211328371.USD","LU0708994859.HKD","LU1267930490.SGD","CCK","LU0310799852.SGD","LU0310800379.SGD","BK4126","PWS","LU1892829315.USD","BK4007"],"gpt_icon":0},{"id":"2614898854","title":"Aardvark Therapeutics down 54% to $5.70 after pausing Phase 3 HERO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898854","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614898854?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:00","pubTimestamp":1772229647,"startTime":"0","endTime":"0","summary":"16:57 EST Aardvark Therapeutics (AARD) down 54% to $5.70 after pausing Phase 3 HERO trial Published first on TheFly – the ultimate source for real-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-down-54-to-5-70-after-pausing-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-down-54-to-5-70-after-pausing-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HERO","AARD"],"gpt_icon":0},{"id":"2614095862","title":"Aardvark Therapeutics voluntarily pauses Phase 3 HERO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2614095862","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614095862?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:11","pubTimestamp":1772226663,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) announced it is voluntarily pausing the Phase 3 Hunger Elimination or Reduction Objective trial. The HERO trial is a P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-voluntarily-pauses-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-voluntarily-pauses-phase-3-hero-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HERO","AARD"],"gpt_icon":0},{"id":"2582775753","title":"Press Release: SurgePays Revenue for the Third Quarter 2025 Increases 292% Year-Over-Year and 62% Sequentially","url":"https://stock-news.laohu8.com/highlight/detail?id=2582775753","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582775753?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:20","pubTimestamp":1762957200,"startTime":"0","endTime":"0","summary":"Third quarter 2025 revenue totaled approximately $18.7 million, an increase of 292% year-over-year and 62% sequentially. Company is reiterating revenue guidance for 2026 of $225 million. BARTLETT, Tenn., Nov. 12, 2025  -- SurgePays, Inc.  , a wireless and fintech technology company connecting subprime and underserved consumers to essential mobile and financial services, today announced revenue growth of 292% year-over-year and 62% sequentially to $18.7 million for the third quarter ended September 30, 2025. The Company is reiterating revenue guidance of $225 million for 2026.Mr. Cox concluded, \"As we continue to scale our platform and expand our leadership across the subprime and underserved markets, we are confident in our ability to deliver strong growth and achieve our 2026 revenue guidance of $225 million.\". -- Torch Wireless, SurgePays' Lifeline-subsidized brand, continued to be a. SurgePays' ability to capture market share in the prepaid wireless. partners, including HT Hackney, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SURG","HERO","BK4132"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HERO\",params:#limit:6,delay:false,,,undefined,":[]}}